| Elizabeth A Mitchell, MD | |
|
805 W La Veta Ave, Suite 103, Orange, CA 92868-3901 | |
| (714) 997-8911 | |
| (714) 997-4911 |
| Full Name | Elizabeth A Mitchell |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 805 W La Veta Ave, Orange, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538233895 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | (Illinois) | Primary |
| Entity Name | Providence Facey Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710031588 PECOS PAC ID: 3173436276 Enrollment ID: O20031105000822 |
News Archive
The Business Software Alliance (BSA), the voice of the world's commercial software industry, today announced a settlement with iCan Benefit Group of Boca Raton, FL. iCan Benefit paid $61,500 to BSA to settle claims that it had unlicensed copies of Adobe, Microsoft and Symantec software installed on its computers. As part of the settlement agreement, the company agreed to delete all unlicensed copies of software from its computers, acquire any licenses necessary to become compliant, and commit to implementing stronger software asset management (SAM) practices.
Researchers from major universities in the U.S. have developed specific tests to identify cancer biomarkers in patients with dermatomyositis-a systemic inflammatory disease associated with increased risk of malignancy.
Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.
Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.
The U.S. military will end its formal earthquake relief mission in Haiti on June 1, but some assistance will continue after that, Lieutenant General Ken Keen said on Monday, Reuters reports.
› Verified 3 days ago
| Entity Name | Exer Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588901532 PECOS PAC ID: 9032359534 Enrollment ID: O20130705000153 |
News Archive
The Business Software Alliance (BSA), the voice of the world's commercial software industry, today announced a settlement with iCan Benefit Group of Boca Raton, FL. iCan Benefit paid $61,500 to BSA to settle claims that it had unlicensed copies of Adobe, Microsoft and Symantec software installed on its computers. As part of the settlement agreement, the company agreed to delete all unlicensed copies of software from its computers, acquire any licenses necessary to become compliant, and commit to implementing stronger software asset management (SAM) practices.
Researchers from major universities in the U.S. have developed specific tests to identify cancer biomarkers in patients with dermatomyositis-a systemic inflammatory disease associated with increased risk of malignancy.
Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.
Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.
The U.S. military will end its formal earthquake relief mission in Haiti on June 1, but some assistance will continue after that, Lieutenant General Ken Keen said on Monday, Reuters reports.
› Verified 3 days ago
| Entity Name | Carbon Health Medical Group Of California Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417294232 PECOS PAC ID: 9032340047 Enrollment ID: O20140314001276 |
News Archive
The Business Software Alliance (BSA), the voice of the world's commercial software industry, today announced a settlement with iCan Benefit Group of Boca Raton, FL. iCan Benefit paid $61,500 to BSA to settle claims that it had unlicensed copies of Adobe, Microsoft and Symantec software installed on its computers. As part of the settlement agreement, the company agreed to delete all unlicensed copies of software from its computers, acquire any licenses necessary to become compliant, and commit to implementing stronger software asset management (SAM) practices.
Researchers from major universities in the U.S. have developed specific tests to identify cancer biomarkers in patients with dermatomyositis-a systemic inflammatory disease associated with increased risk of malignancy.
Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.
Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.
The U.S. military will end its formal earthquake relief mission in Haiti on June 1, but some assistance will continue after that, Lieutenant General Ken Keen said on Monday, Reuters reports.
› Verified 3 days ago
| Entity Name | Continuem |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336716489 PECOS PAC ID: 7911302955 Enrollment ID: O20210830000400 |
News Archive
The Business Software Alliance (BSA), the voice of the world's commercial software industry, today announced a settlement with iCan Benefit Group of Boca Raton, FL. iCan Benefit paid $61,500 to BSA to settle claims that it had unlicensed copies of Adobe, Microsoft and Symantec software installed on its computers. As part of the settlement agreement, the company agreed to delete all unlicensed copies of software from its computers, acquire any licenses necessary to become compliant, and commit to implementing stronger software asset management (SAM) practices.
Researchers from major universities in the U.S. have developed specific tests to identify cancer biomarkers in patients with dermatomyositis-a systemic inflammatory disease associated with increased risk of malignancy.
Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.
Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.
The U.S. military will end its formal earthquake relief mission in Haiti on June 1, but some assistance will continue after that, Lieutenant General Ken Keen said on Monday, Reuters reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth A Mitchell, MD 805 W La Veta Ave, Suite 103, Orange, CA 92868-3901 Ph: (714) 997-8911 | Elizabeth A Mitchell, MD 805 W La Veta Ave, Suite 103, Orange, CA 92868-3901 Ph: (714) 997-8911 |
News Archive
The Business Software Alliance (BSA), the voice of the world's commercial software industry, today announced a settlement with iCan Benefit Group of Boca Raton, FL. iCan Benefit paid $61,500 to BSA to settle claims that it had unlicensed copies of Adobe, Microsoft and Symantec software installed on its computers. As part of the settlement agreement, the company agreed to delete all unlicensed copies of software from its computers, acquire any licenses necessary to become compliant, and commit to implementing stronger software asset management (SAM) practices.
Researchers from major universities in the U.S. have developed specific tests to identify cancer biomarkers in patients with dermatomyositis-a systemic inflammatory disease associated with increased risk of malignancy.
Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.
Xencor, Inc. announced today that the Company received a milestone payment from Boehringer Ingelheim. The payment was triggered by the regulatory submission for Phase 1 clinical trials of a novel monoclonal antibody that was optimized using one of Xencor's XmAb Fc (constant fragment) technology platforms under a technology license agreement entered in February 2007.
The U.S. military will end its formal earthquake relief mission in Haiti on June 1, but some assistance will continue after that, Lieutenant General Ken Keen said on Monday, Reuters reports.
› Verified 3 days ago
Joseph Villarreal, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Building 1a, Room 1009, Orange, CA 92868 Phone: 714-456-5239 | |
Scott Rudkin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-2986 | |
Joelle Reynard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Building 1a, Room 1009, Orange, CA 92868 Phone: 714-456-5239 | |
Dr. Inna Shniter, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8113 | |
John C Fox, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-2986 | |
Miss Shannon Louise Toohey, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Drive South, Bldg 200 , Suite 710, Rt 128-01, Orange, CA 92868 Phone: 715-456-5239 | |
Wirachin Hoonpongsimanont, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-5705 |